Comerica Bank
PGNX

Comerica Bank’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Comerica Bank’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-83,367
Closed -$343K – 2317
2020
Q1 		$343K Buy
83,367
+2,530
+3% +$10.9K ﹤0.01% 1908
2019
Q4 		$377K Buy
80,837
+1,505
+2% +$7.96K ﹤0.01% 1994
2019
Q3 		$386K Buy
79,332
+1,447
+2% +$7.22K ﹤0.01% 1974
2019
Q2 		$418K Sell
77,885
-5,878
-7% -$28.3K ﹤0.01% 1955
2019
Q1 		$422K Buy
83,763
+3,547
+4% +$16K ﹤0.01% 1955
2018
Q4 		$359K Sell
80,216
-358
-0.4% -$1.82K ﹤0.01% 1994
2018
Q3 		$427K Buy
80,574
+2,746
+4% +$21.1K ﹤0.01% 1948
2018
Q2 		$640K Buy
77,828
+4,466
+6% +$34.1K ﹤0.01% 1855
2018
Q1 		$515K Buy
73,362
+1,198
+2% +$7.97K ﹤0.01% 1896
2017
Q4 		$478K Sell
72,164
-1,907
-3% -$11.6K ﹤0.01% 1945
2017
Q3 		$453K Buy
74,071
+891
+1% +$5.66K ﹤0.01% 1927
2017
Q2 		$486K Sell
73,180
-4,136
-5% -$30.5K ﹤0.01% 1845
2017
Q1 		$597K Buy
+77,316
New +$772K ﹤0.01% 1811

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Comerica Bank's PGNX Position: Q2 2020 in Review

Comerica Bank sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 83,367 shares — an estimated $343K sold.

Comerica Bank first reported a position in PGNX in Q1 2017 and held it in 13 quarters. The position peaked at $640K in Q2 2018. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Comerica Bank reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Comerica Bank sold 83,367 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $343K.
  • Comerica Bank first reported a position in Progenics Pharmaceuticals Inc in Q1 2017 and held it in 13 quarters.
  • Comerica Bank's Progenics Pharmaceuticals Inc position peaked at $640K in Q2 2018.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Comerica Bank's 13F filing for Q2 2020, filed 31 Jul 2020.